SF 2322: Relating to insurance coverage for prescription insulin drugs

What it does

This bill relates to prescription insulin drugs and coverage by policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs. The bill requires a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses that provides coverage for prescription drugs to cap the total amount of cost-sharing that a covered person is required to pay per prescription filled of an insulin drug to an amount not more than $35 for an up to 31-day supply of at least one type of rapid-acting prescription insulin drugs, short-acting prescription insulin drugs, intermediate-acting prescription insulin drugs, or long-acting prescription insulin drugs.

Senate subcommittee · named February 19, 2026

• Sen. Kara Warme (R) · kara.warme@legis.iowa.gov
• Sen. Adrian Dickey (R) · adrian.dickey@legis.iowa.gov
• Sen. Catelin Drey (D) · catelin.drey@legis.iowa.gov

In plain words

1. February 12, 2026Filed in the Senate and sent to the Commerce committee
2. February 19, 2026Senate subcommittee named: Warme, Dickey and Drey